Back to Trades
McKechnie Duncan
EVPChief Commercial OfficerCIK 0002062139
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2026
McKechnie Duncan, EVP, Chief Commercial Officer, has filed 4 SEC reports (2026), all concentrated in VERTEX PHARMACEUTICALS INC / MA (VRTX), totaling $4.7M in disclosed volume. Weighing $0 bought versus $3.2M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jul 7 | VRTX VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | $799.8K |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | $2.4M |
| Feb 19 | VRTX VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan | EVP, Chief Commercial Officer | Grant | $555.3K |
| Feb 12 | VRTX VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan | EVP, Chief Commercial Officer | Tax withheld | $527.9K |
4 filings